Medimaging Integrated Solution Inc. (TPE:6796)
Taiwan · Delayed Price · Currency is TWD 52.00
+1.60 (3.17%)
Sep 18, 2026, 1:30 PM CST
TPE:6796 Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,092 | 3,602 | 3,020 | 3,770 | 2,379 | 2,019 | |
Market Cap Growth | -24.42% | 19.27% | -19.89% | 58.45% | 17.81% | - |
Enterprise Value | 2,147 | 3,737 | 3,065 | 3,620 | 2,177 | 1,953 |
Last Close Price | 52.00 | 93.80 | 77.06 | 94.92 | 60.78 | 55.84 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 141.95 | 466.23 | 538.29 | 50.90 | 33.98 | 30.38 |
Forward PE | - | 37.70 | 37.70 | 37.70 | 37.70 | - |
PS Ratio | 3.07 | 5.45 | 5.60 | 7.02 | 4.74 | 4.16 |
PB Ratio | 2.45 | 4.83 | 4.07 | 4.76 | 3.67 | 4.15 |
P/TBV Ratio | 2.53 | 5.02 | 4.22 | 4.86 | 3.74 | 4.27 |
P/FCF Ratio | - | - | - | - | 37.22 | 102.72 |
P/OCF Ratio | - | - | - | 22.31 | 21.09 | 43.95 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.15 | 5.65 | 5.69 | 6.74 | 4.34 | 4.02 |
EV/EBITDA Ratio | 44.98 | 55.80 | 72.18 | 30.33 | 25.45 | 16.93 |
EV/EBIT Ratio | - | 208.56 | - | 39.39 | 36.53 | 22.54 |
EV/FCF Ratio | - | - | - | - | 34.06 | 99.33 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.78 | 0.90 | 0.60 | 0.51 | 0.14 | 0.27 |
Debt / EBITDA Ratio | 13.99 | 9.28 | 9.02 | 3.31 | 0.99 | 1.11 |
Debt / FCF Ratio | - | - | - | - | 1.37 | 6.65 |
Net Debt / Equity Ratio | 0.06 | 0.18 | 0.09 | -0.32 | -0.38 | -0.21 |
Net Debt / EBITDA Ratio | 1.29 | 1.96 | 1.60 | -2.12 | -2.89 | -0.90 |
Net Debt / FCF Ratio | -0.76 | -2.81 | -0.40 | 10.97 | -3.87 | -5.27 |
Asset Turnover | 0.46 | 0.45 | 0.40 | 0.49 | 0.65 | 0.73 |
Inventory Turnover | 1.68 | 1.70 | 1.73 | 1.53 | 1.74 | 1.96 |
Quick Ratio | 1.80 | 1.65 | 2.64 | 4.65 | 3.74 | 2.40 |
Current Ratio | 2.54 | 2.26 | 3.69 | 5.67 | 5.13 | 3.37 |
Return on Equity (ROE) | 1.85% | 1.04% | 0.73% | 10.28% | 12.35% | 15.17% |
Return on Assets (ROA) | -0.31% | 0.77% | -0.18% | 5.27% | 4.78% | 8.12% |
Return on Invested Capital (ROIC) | -0.57% | 1.12% | -0.26% | 15.57% | 12.19% | 19.65% |
Return on Capital Employed (ROCE) | -0.60% | 1.60% | -0.30% | 7.80% | 8.30% | 15.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.68% | 0.21% | 0.19% | 1.96% | 2.94% | 3.29% |
FCF Yield | -3.42% | -1.30% | -5.57% | -0.61% | 2.69% | 0.97% |
Dividend Yield | 0.48% | 0.27% | 0.65% | 1.72% | 2.69% | 2.88% |
Payout Ratio | 121.34% | 224.97% | 1109.63% | 80.76% | 75.97% | 54.18% |
Buyback Yield / Dilution | -2.37% | 0.09% | -2.40% | -5.14% | -10.01% | -2.10% |
Total Shareholder Return | -1.89% | 0.36% | -1.75% | -3.41% | -7.32% | 0.78% |